BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 16000397)

  • 41. Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization.
    Homayounfar K; Gunawan B; Cameron S; Haller F; Baumhoer D; Uecker S; Sander B; Ramadori G; Lorf T; Füzesi L
    Hum Pathol; 2009 Jun; 40(6):834-42. PubMed ID: 19200581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
    Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
    Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction.
    Yen CC; Chen YJ; Lu KH; Hsia JY; Chen JT; Hu CP; Chen PM; Liu JH; Chiou TJ; Wang WS; Yang MH; Chao TC; Lin CH
    Int J Oncol; 2003 Oct; 23(4):871-81. PubMed ID: 12963965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses.
    Nishimura T; Nishida N; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
    Cancer Genet Cytogenet; 2006 May; 167(1):57-65. PubMed ID: 16682288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
    Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
    Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridisation in Taiwan.
    Lin YW; Sheu JC; Huang GT; Lee HS; Chen CH; Wang JT; Lee PH; Lu FJ
    Eur J Cancer; 1999 Apr; 35(4):652-8. PubMed ID: 10492642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization.
    Nakao K; Mehta KR; Fridlyand J; Moore DH; Jain AN; Lafuente A; Wiencke JW; Terdiman JP; Waldman FM
    Carcinogenesis; 2004 Aug; 25(8):1345-57. PubMed ID: 15001537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma.
    Kusano N; Okita K; Shirahashi H; Harada T; Shiraishi K; Oga A; Kawauchi S; Furuya T; Sasaki K
    Cancer; 2002 Feb; 94(3):746-51. PubMed ID: 11857308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.
    Roessler S; Long EL; Budhu A; Chen Y; Zhao X; Ji J; Walker R; Jia HL; Ye QH; Qin LX; Tang ZY; He P; Hunter KW; Thorgeirsson SS; Meltzer PS; Wang XW
    Gastroenterology; 2012 Apr; 142(4):957-966.e12. PubMed ID: 22202459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of chromosomal aberrations in large hepatocellular carcinomas by comparative genomic hybridization.
    Kitay-Cohen Y; Amiel A; Ashur Y; Fejgin MD; Herishanu Y; Afanasyev F; Bomstein Y; Lishner M
    Cancer Genet Cytogenet; 2001 Nov; 131(1):60-4. PubMed ID: 11734320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8.
    De Bortoli M; Castellino RC; Lu XY; Deyo J; Sturla LM; Adesina AM; Perlaky L; Pomeroy SL; Lau CC; Man TK; Rao PH; Kim JY
    BMC Cancer; 2006 Sep; 6():223. PubMed ID: 16968546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization.
    Pang E; Wong N; Lai PB; To KF; Lau JW; Johnson PJ
    Cancer Genet Cytogenet; 2000 Aug; 121(1):9-16. PubMed ID: 10958934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization.
    Hurst CD; Fiegler H; Carr P; Williams S; Carter NP; Knowles MA
    Oncogene; 2004 Mar; 23(12):2250-63. PubMed ID: 14968109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
    Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.
    Weber RG; Pietsch T; von Schweinitz D; Lichter P
    Am J Pathol; 2000 Aug; 157(2):571-8. PubMed ID: 10934159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas.
    Tornillo L; Carafa V; Richter J; Sauter G; Moch H; Minola E; Gambacorta M; Bianchi L; Vecchione R; Terracciano LM
    J Pathol; 2000 Nov; 192(3):307-12. PubMed ID: 11054713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
    Schlaeger C; Longerich T; Schiller C; Bewerunge P; Mehrabi A; Toedt G; Kleeff J; Ehemann V; Eils R; Lichter P; Schirmacher P; Radlwimmer B
    Hepatology; 2008 Feb; 47(2):511-20. PubMed ID: 18161050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
    Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.